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Background: Intimate partner violence (IPV) and its associated negative mental health consequences are significant
for women in New Zealand and internationally. One of the most widely recommended interventions is safety
planning. However, few women experiencing violence access specialist services for safety planning. A safety
decision aid, weighing the dangers of leaving or staying in an abusive relationship, gives women the opportunity
to prioritise, plan and take action to increase safety for themselves and their children. This randomised controlled
trial is testing the effectiveness of an innovative, interactive web-based safety decision aid. The trial is an international
collaborative concurrent replication of a USA trial (IRIS study NCT01312103), regionalised for the Aotearoa New Zealand
culture and offers fully automated online trial recruitment, eligibility screening and consent.
Methods/Design: In a fully automated web-based trial (isafe) 340 abused women will be randomly assigned in equal
numbers to a safety decision aid intervention or usual safety planning control website. Intervention components
include: (a) safety priority setting, (b) danger assessment and (c) an individually tailored safety action plan.
Self-reported outcome measures are collected at baseline and 3, 6, and 12-months post-baseline.
Primary outcomes are depression (measured by Center for Epidemiologic Studies Depression Scale, Revised) and IPV
exposure (measured by Severity Violence Against Women Scale) at 12 months post-baseline. Secondary outcomes
include PTSD, psychological abuse, decisional conflict, safety behaviors and danger in the relationship.
Discussion: This trial will provide much-needed information on the potential relationships among safety planning,
improved mental health, reduced violence as well as decreased decisional conflict related to safety in the abusive
relationship. The novel web-based safety decision aid intervention may provide a cost-effective, easily accessed
safety-planning resource that can be translated into clinical and community practice by multiple health disciplines
and advocates. The trial will also provide information about how women in abusive relationships safely access safety
information and resources through the Internet. Finally, the trial will inform other research teams on the feasibility
and acceptability of fully automated recruitment, eligibility screening, consent and retention procedures.
Trial registration: Trial registered on 03 July 2012 on the Australian New Zealand Clinical Trials Registry
ACTRN12612000708853.
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Intimate partner violence (IPV) is a widespread problem
with significant negative health outcomes for survivors
and their families [1-3]. Beyond the well-known negative
physical health impacts, research consistently demon-
strates a strong association between IPV and increased
rates of depression, post-traumatic stress disorder (PTSD),
substance abuse and suicide [4-6]. One of the most widely
recommended interventions for abused women is safety
planning [7-9]. The safety process involves a woman con-
sidering complex individual, cultural and community fac-
tors, such as financial needs and well-being of children.
The challenge is to help women experiencing abuse to
identify safety priorities and develop a personalised safety
plan while considering staying or leaving an abusive rela-
tionship. In response to the challenge, USA researchers
developed and are testing the first interactive, web-based
safety decision aid for women experiencing IPV [10]. Pre-
liminary findings suggest that women randomised to the
safety decision aid reported less decisional conflict about
their safety in the abusive intimate relationship after one
use compared to women randomised to the usual safety
planning condition [11]. While the USA-based IRIS study
is the first trial to report on the evaluation of a decision
aid for IPV survivors, the initial findings are consistent
with a Cochrane systematic review that identified 115 tri-
als testing health related decision aids [12]. The review re-
ported that decision aids improve knowledge, create more
accurate expectations of possible harms and benefits, in-
crease active decision-making, and reduce the proportion
of participants who report being undecided.
The New Zealand (isafe) research study is part of an
international collaborative and concurrent replication of
the USA IRIS trial (NCT01312103) testing the effective-
ness of an interactive web-based safety decision aid in
improving mental health and reducing IPV exposure. In
the first phase of the New Zealand study, focus groups
with service providers and women experiencing IPV in-
formed regionalising the IRIS safety decision aid for the
New Zealand context [13]. In addition to cultural tailoring
[14], the New Zealand trial advances the IRIS study by
offering women fully automated online trial recruitment,
eligibility screening, consent and retention procedures.
Methods/Design
Trial design
The isafe trial design is a two-arm, parallel, randomised
controlled trial to test the effectiveness of a web-based
safety decision aid intervention on mental health and
IPV exposure with abused women. The isafe trial in
Aotearoa New Zealand involves a Māori Kaumatua
(respected person who is a recognised elder) to advise
and guide the researchers in the development and imple-
mentation of the trial to ensure processes are culturallyresponsive to Māori (New Zealand’s indigenous peoples)
and to ensure the trial optimises Māori involvement. The
trial protocol was developed to align with researcher
agreed tikanga (principles) that included for example,
‘Respect and optimise the mana/status, tapu/safety and
welfare of the wāhine/women, tamariki/children and
whānau/family’. To increase trial access for women with a
disability, the website addressed Web Content Accessibility
Guidelines [15] and provided an audio option. The proto-
col is described according to the CONSORT-EHEALTH
checklist [16].
Primary hypotheses are that: At 12 months post-
baseline the intervention group (safety decision aid), in
comparison to the control group (usual safety planning),
will have: (1) improved mental health and (2) reduced
IPV exposure. Secondary hypotheses are: At 3 and
6 months post-baseline the intervention group, in com-
parison to the control group, will have: (1*) improved
mental health and (2*) reduced IPV exposure. At 3, 6
and 12 months post-baseline the intervention group, in
comparison to the control group, will have: (3) increased
safety-seeking behaviours and (4) less decisional conflict
related to safety. Also, (5) increased benefit (improved
mental health and reduced IPV exposure) from the inter-
vention will occur under increased safety-seeking behav-
iours and less decisional-conflict at 3, 6 and 12 months.
The effects on each outcome of the interaction between
time and intervention arm, and of safety decision aid usage
level, will form additional secondary hypotheses.
Participants and recruitment
The target population is English-speaking adult women
(≥16 years) residing in New Zealand who report current
IPV. Current IPV is determined by a positive response
to one or more of the following: (a) In the last 6 months,
the woman has been hit, kicked, punched, choked
(strangled) or otherwise physically hurt by the current
partner; (b) In the last 6 months, the woman’s partner
forced sexual activities or coerced her into sexual activ-
ities with threats; (c) In the last 6 months, the woman’s
partner threatened to harm her physically; or (d) In
the last 6 months, the woman has felt unsafe in the
relationship.
Eligible women need to express comfort with their
ability to access a safe and secure computer to login to
the trial website. They also need access to a safe email,
meaning they are the only one with password access to the
account, to send and receive study-related information.
We conservatively seek to enrol an average of 43
women per quarter. This target is based on population-
based 12-month partner violence prevalence rates esti-
mated at 4 to 6% [2,17]; on calculated nationwide
monthly averages [18] of 6,040 police domestic violence
attendances and 4,125 crisis calls to Women’s Refuge;
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trial experience of 46 successful enrolments per quarter.
Women are recruited to the fully automated web-
based study by registering on the trial site at www.isafe.
aut.ac.nz. Strategies alerting women to the trial include
referral to the site by community partners (specialist do-
mestic violence agencies and police) and a range of so-
cial media advertisements which request volunteers for a
confidential research study on safety in relationships.
Such advertisements are made available on healthcare
site-based TV, YouTube, Twitter and domestic violence
and general social media websites. A free phone number
is available for women to call with queries.
Safety and security
The trial protocol was approved by the Auckland
University of Technology Ethics Committee (AUTEC)
in April, 2012. Safety protocols and research team
training addressed safety assessment for women and
their children, safe use of computers and internet,
and IPV and suicidality resource referrals. Expecting
a significant proportion of participants to have symp-
toms consistent with depression and suicidality [19],
a message is included at the end of the depression scale
(CESD-R) for all women that acknowledged ‘feeling
down’, that ‘it’s important that you tell someone you trust
how you are feeling’ and offers community-based referral
information.
A data monitoring committee (DMC) meets 6 monthly
during the trial. A DMC Charter outlines responsibility for
safeguarding the interests of trial participants, assessing the
safety and efficacy of the interventions during the trial, and
for monitoring the overall conduct of the trial. Any un-
anticipated problems potentially related to isafe are re-
ported to the DMC and AUTEC chairpersons.
Procedures
Participants enrol in the study by accessing a secure New
Zealand registration trial website (www.isafe.aut.ac.nz).
The site provides a full description of the trial with poten-
tial risks and benefits. A participant is considered enrolled
if they have visited the registration website and: met eligi-
bility criteria (16 years or older, English language, current
IPV), consented to participate, provided contact informa-
tion, and been validated as a female resident in New
Zealand. During registration, women are asked how
they may be safely contacted and details for a contact per-
son who would be able and willing to safely pass on a mes-
sage to her should we lose connection with her during the
12-month follow up period.
With a fully automated online trial recruitment, a
validation process was used to minimise the risk of
fraudulent participant entry (such as duplicate entry).
Validation is either automated (matching the consentingparticipant’s name and address against the New Zealand
Electoral Roll file provided 09 May 2012) or manual valid-
ation. Manual validation is completed by a research team
member conducting a logic check of participant informa-
tion (such as birthday) against information gathered by
Google and Face Book searching or alternatively by send-
ing an e-mail requesting confirmation of electoral roll sta-
tus from the participant. When unsure about a validation,
research team members, with the PI, consult for a final
decision.
Once enrolled, a woman is randomised by computer
algorithm to either the intervention or control group
and sent an e-mail with a username, password and URL
access for either the intervention or control website. The
woman has a 6 week window to enter the secure website
and complete the baseline survey. Automated ‘reminder’
e-mails are sent during the 6 week window. Once a
woman completes the baseline measures she is consid-
ered ‘accrued’. A woman who does not complete the
baseline measures in the allocated time frame (within
6 weeks of enrolment) is considered ‘off study’.
Completion of study measures and either the safety
decision aid or usual safety planning is estimated to take
45 to 60 minutes at each time point, a feasible time for
participants to have web access and not be regarded as
overly burdensome [13,20,21]. If women have to quit
during a session they are able to log-in to the site at a
later time. As a token of appreciation for participation,
women provide a safe postal address to receive a $30 gift
voucher at each measurement point (baseline, 3, 6 and
12 months).
To maintain contact with participants over the 12
month follow up period, automated emails are sent to
participants at 1, 2, 4, 8 and 10 months. Retention mech-
anisms such as sending an email and or phoning partici-
pants at their provided ‘safe contact’ are initiated once
women are ‘late’ for a follow up visit following safety
protocols. This includes only using safe contact num-
bers/emails as provided by the participant. Logs are
maintained by study personnel documenting phone and
email contacts with participants, potential unanticipated
events, and other issues affecting the trial (such as server
interruptions).
Safety decision aid intervention group
Women randomly assigned to the safety decision aid
intervention group will be able to access the safety deci-
sion aid throughout the one-year study period via the se-
cure password-protected trial website. The intervention
includes three components: safety priority setting, dan-
ger assessment [22] and personalised safety action plan.
The safety priority setting activity is based on a multi-
criteria decision model [10]. The five criteria (priorities)
listed in Table 1 were evaluated for the New Zealand
Table 1 Safety priority criteria
Priorities Descriptions
Having resources Having housing and income.
Keeping my privacy Issues in my relationship are not something
I share with others.
My child’s well-being Concerns for the well-being and safety of
my child or children.
Feelings for my partner Love or concern for my partner.
My concern for safety Safety of myself, whānau, family and friends.
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descriptions. Women move a sliding bar toward the pri-
ority that is most important for all possible pairwise
combinations. Through a series of matrix computations
using the Analytic Hierarchy Process, the programme
provides feedback to the woman, summarising her
priorities.
For the second component of the safety decision aid,
women are asked to complete the Danger Assessment
(DA) or Danger Assessment-Revised (for female same-
sex relationships) and receive scored immediate feed-
back on their level of danger for severe or lethal violence
in the intimate relationship, ranging from variable to ex-
treme danger [23-27]. The DA includes a calendar to
help women identify the frequency and severity of abuse
and 19 lethality risk indicators related to the abusive
partner’s behaviour and 1 item related to her risk of sui-
cide. Once women receive feedback (based on summary
score of the 19 items), they then have the opportunity to
change their safety priorities. For example, if their dan-
ger level is higher than they expected, they may wish to
make changes in their safety priorities.
The third and final safety decision aid intervention
component is an interactive process using an underlying
matrix of resources to help women develop an individu-
ally tailored action plan. The action plan lays out local,
regional or national resources and tips about safety for
the women and their children based on their safety pri-
orities and DA scores. For example, women who screen
positive for suicidality will receive messages with referral
to their health provider as well as suicide prevention re-
sources (Depression Helpline 0800 111 757 or Lifeline
0800 111 777). If women determine it is safe, they can
print a copy of the personalised report with their ac-
tion plan.
Usual safety planning control group
Women randomly assigned to the control group will be
able to access a list of contact details for key sources of
support for partner violence throughout the one-year
study period via the secure password-protected trial
website. All control group women receive the samestandardised list of resources and a standardised emer-
gency safety plan, like those usually provided by domestic
violence advocates, national hotlines or websites. Resources
are not individualised to the safety needs of the woman as
they do not complete the safety priority setting activity nor
do they complete the DA. They are not provided with indi-
vidualised feedback for an action plan.
Outcomes
The primary outcomes consist of
(a) Mental health primary outcome: depression
measured by the Center for Epidemiologic Studies
Depression Scale, Revised (CESD-R) [28,29]. The
CESD-R includes 20 depressive symptoms reflective
of the DSM-IV criteria for depression. Participants
respond ‘how often you have felt this way in the past
week or so’ selecting one of five response options from
‘not at all or less than 1 day’ to ‘nearly every day
for two weeks’. The total CESD-R Score may range
from 0 to 60 (based on a CESD style score; see
http://cesd-r.com/cesdr/) with scores of at least 16
indicative of depression. The CESD-R correlates
highly with the original CESD and has strong
psychometric properties (e.g., Cronbach's α > 0.90)
in community samples [28-30].
(b) IPV exposure primary outcome: Severity of Violence
Against Women Scale (SVAWS) [31]. The 46-item
scale includes threats of violence (19 items; score
may range from 19 to 76), acts of violence (21
items) and sexual violence (6 items). Participants
select the frequency of the acts from ‘never’ (1) to
‘many times (4). The referent time period for this
study was the past 6 months (at baseline and
12 month follow up) and the past 3 months (at 3
and 6 month follow up). Previous research has
demonstrated good internal reliability (α = 0.90,
0.93 and 0.84 for the three subscales respectively)
[32]. Researchers commonly report the threats of
violence score (possible range 19 to 76) and actual
violence (possible range 27 to 108) [32,33].
Secondary outcomes include
(c) Mental health secondary outcomes: PTSD Checklist,
Civilian Version (PCL-C) [34,35], Alcohol Use
Disorder Identification Test (AUDIT) [36,37], Drug
Abuse Screening Tool (DAST-10) [38];
(d) IPV exposure secondary outcome: Women’s
Experiences with Battering (WEB) [39];
(e) Decisional conflict secondary outcome: Decisional
Conflict Scale [40];
(f ) Safety seeking behaviour secondary outcome: Safety
Checklist [41,42];
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Danger Assessment – Revised (for same sex couples)
[23-26]; brief gambling screen [43,44]; and
relationship intention.
Randomisation and blinding
Computerised randomisation is based on a minimisation
scheme which is a form of covariate adaptive randomisa-
tion and has the advantage of eliminating expected co-
variate imbalance. Two stratification factors (severity of
violence and women with children) and 2 random fac-
tors each with 2 equiprobable levels are used to achieve
the minimisation. Severity of violence factor based on
one positive response to the current IPV eligibility items
versus two or more. The children factor is based on the
woman having one or more children versus none. All
New Zealand trial investigators and team members are
blinded to group assignment, with the exception of the
data manager (JC) and trial statistician (ACV), who
are responsible for the production of data monitoring
reports.
Statistical analysis
Descriptive statistics (including standard errors) for
baseline outcome values and demographics will be
produced by study arm. Additionally, we will monitor
and collect information on women’s use of the website
by both control and intervention participants to evalu-
ate which information is accessed, skipped, or accessed
over time.
The primary efficacy analyses will test Hypotheses 1
and 2 with outcomes (a) and (b) respectively. Secondary
efficacy analyses will test Hypotheses 1 and 1* with out-
comes (a) and (c); hypotheses 2 and 2* with outcomes
(b) and (d); and hypotheses 3 and 4 with outcomes
(e) and (f) respectively. All efficacy analyses will proceed
on the basis of an assumed normal distribution for the re-
siduals of the outcomes after regressing on the interven-
tion arm and the baseline value. The underlying normality
of the data will be assessed visually and using the omnibus
K2 test [45]. Should non-normality be concluded, adequate
alternative generalised linear models will be sought first,
and appropriate transformations will be considered sec-
ond. This evaluation will occur as part of the blind review.
The data will be analysed using linear mixed models,
wherein normally distributed random intercepts will be
ascribed to each participant and an appropriate covariance
structure selected for longitudinal measurements. All re-
peated measures data for an outcome, if available, will be
included in the model, and appropriate contrasts esti-
mated and tested to address the specific hypotheses.
In further secondary analyses, the effect of the inter-
vention will be assessed in interaction with time. In
addition, among the intervention group, we will examinethe relationship between the number of times or “dose”
the safety decision aid was used during the year and
change from baseline to 12 months in the outcomes of
safety seeking behaviours and exposure to violence using
multiple regression. These analyses will proceed accord-
ing to the same modelling framework as other efficacy
analyses.
We will conduct planned subgroup analyses for each
of hypotheses 1, 1*, 2, 2*, 3 and 4 and their associated
outcomes. We will examine race/ethnicity, rural versus
urban residence, and access to formal services as possible
moderators of the effect of the intervention. Subgroup ana-
lyses will be conducted by considering the interaction be-
tween each subgroup and the intervention arm.
Hypothesis 5 will be tested by fitting a structural equa-
tions model with intervention as exogenous variable and
safety-seeking behaviour and decision-making scores as
endogenous, or mediation, variables to explain depres-
sion and violence scores (along with intervention arm).
The repeated measures character of the data will be inte-
grated in the model by including intercepts and me-
diating effects as participant-level random effects. This
approach corresponds to the 1→ 1→ 1 lower level medi-
ation model in Bauer et al. [46], who also provide a method
to fit such a model with standard linear mixed modelling
software. The structural coefficient estimates associated
with safety-seeking and decision-making, as well as the
intervention, and their 95% confidence intervals will be
reported.
Bias may arise in the analysis if the intervention is ef-
fective and dropouts (women lost to follow up) are non-
ignorable (NI), that is, dependent upon the values of
unobserved outcomes [47,48]. We will model the out-
comes simultaneously with the dropout process using
pattern-mixture latent-class models for Hypotheses 1–4,
1* and 2* [49,50]. This approach has been shown to re-
duce bias considerably in settings including mental
health studies [50,51], and to be implementable using
conventional statistical software such as SAS v.9.4 [51].
An attempt at extending the pattern-mixture latent class
approach to the analysis of Hypothesis 5 will be made.
Results from the joint outcome-NI dropout models will
be presented along with the secondary analyses.
A blind review will be carried out at the end of follow-
up to assess normality of residuals (excluding the treat-
ment arm as regressor) and determine the best family or
transformation to use if normality is rejected; to assess
the appropriateness of the missing value strategies; to
identify covariates that may improve efficiency or allay
bias in case of imbalance; to identify an appropriate co-
variance structure for the repeated longitudinal mea-
sures; and to determine whether efficiency gains can be
made by accounting for the covariance between the pri-
mary outcomes in the primary analyses.
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treat analysis set. Secondary analyses of primary out-
comes will also be conducted in a per protocol analysis
set. Unmodified p-values will be reported for all tests,
but inference for primary analyses will be based on False
Discovery Rate controlled p-value thresholds accounting
for the two outcomes. The nominal level for significance
testing will be 5% against two-sided alternatives. All esti-
mates of intervention effect will be reported as point es-
timates and 95% confidence intervals.
Sample size
We estimate the required recruitment goal at 340 women.
This figure is based on a need for 113 complete assess-
ments per arm, accounting for an upper limit of 35%
attrition by 12 months, based on rates from previous web-
based studies (e.g., the RID trial, see http://www.otago.ac.
nz/rid/). The estimated recruitment rate (43 women per
quarter) will achieve the desired sample size over 36-
month accrual period.
In regard to CESD-R: existing literature [28,52] is
consistent with a correlation between baseline and 12-
month CES-D/CESD-R measurements of about 0.5, con-
sistent with a value of 0.47 deduced from data from a
recent NZ trial [19]. Based on these data, we estimate
that the planned study will have 80% power to detect a
30% decrease in the CESD-R depression score, at a 5%
nominal confidence level Bonferroni-corrected for the
two primary hypotheses. Based on these same data, this
reduction represents an estimated relative decrease of
30.1% in the number or women at or above the cut-off
of 16 for CESD-R, indicating depression. The detectable
score reduction also corresponds to an effect size of 0.40
based on our data. (There is no established minimum
clinically important difference for CESD-R).
In regard to SVAWS: we obtained an estimate of 29.2
for the standard deviation of the overall SVAWS, using
pooled estimates of subscores from an international IPV
study [53] and inferring subscore correlations from an-
other [54]. The latter study also yielded an estimated
correlation for the SVAWS at baseline and 12 months
of 0.32. These indicate that the proposed study will
have power 80% to detect a difference of −11.4 in IPV
exposure, corresponding to an effect size of 0.39, at a
Bonferroni-corrected nominal 5% significance level. We
note that the Bonferroni correction is conservative with
respect to False Discovery Rate control, and that gains in
power are expected from the use of the repeated mea-
sures in the analysis.
Discussion
This trial will provide information on the potential rela-
tionships among safety planning, reduction of decisional
conflict, exposure to violence and mental health. Thenovel intervention used in this trial and its automated
web-based delivery may set a new standard for safety
planning that includes risk assessment, priority setting
for decision making and creation of a personalised safety
action plan. The web-based safety decision intervention
may provide a cost-effective, evidence-based safety-
planning tool that could be translated into practice by mul-
tiple health disciplines and advocates. The trial will also
provide information about women in abusive relationships
safely accessing the web and the experience of fully auto-
mated recruitment and retention processes.
Trial status
Active follow up.
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